BLINCYTO (Blinatumomab) for injection 35 mcg/vial

BLINCYTO (Blinatumomab) for injection 35 mcg/vial

Kategori: Drug Info Tersedia
Untuk informasi lebih lanjut, kunjungi situs resmi kami di farmakopedia.com

Deskripsi

Manufacturer
Amgen Biopharmaceuticals Malaysia Sdn Bhd
 
Contents
Blinatumomab
 
Indication
Minimal residual disease (MRD) positive, relapsed or refractory B-cell precursor acute lymphoblastic leukemia (ALL).
 
Drug interaction
Monitor for toxicity (eg, warfarin) or drug conc (eg, cyclosporine) w/ CYP450 substrates.

Lihat detail lebih lanjut tentang Complete Wellness
Complete Wellness
Complete Wellness General Health | Healthy Lifestyle | Drug & Supplement Information Provider ~Complete Wellness